USPTO serial 87126892
XEMYS
Reviewed by CopyMark Law Group
Reg. 5461700Status 710
- Filing date
- Status date
- Registration date
- May 8, 2018
- Examiner
- EULIN, INGRID C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with XEMYS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for the treatment of multiple sclerosis; chemical preparations for pharmaceutical or medical purposes, namely, for treatment of multiple sclerosis or prevention of relapses of multiple sclerosis; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; human vaccine preparations; hormones; medical preparations for the treatment of multiple sclerosis; medicaments for delaying of multiple sclerosis progression and reduce of multiple sclerosis relapses; mixed biological preparations for the prevention and treatment of infectious diseases; mixed hormone preparations; molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; multivitamin preparations; multi-vitamin preparations; nasal and oral spray preparations for use as central nervous system stimulants; nasal spray preparations; nose drops; pain relief medication; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention of relapses of multiple sclerosis; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of multiple sclerosis; pharmaceutical preparations for treatment of multiple sclerosis or prevention of relapses of multiple sclerosis; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; preparation for the relief of pain; reagents for medical use; steroids; synthetic peptides for the treatment of multiple sclerosis; therapeutic pharmaceutical for the treatment of multiple sclerosis; vaccine preparations; vaccines; vitamin and mineral preparations for medical use; vitamins | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 22, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| May 8, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 8, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 20, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 20, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 31, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 18, 2018 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jan 12, 2018 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jan 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 29, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 29, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 22, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 24, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 24, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 24, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 31, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 24, 2017 | ALIE | ASSIGNED TO LIE | — |
| Nov 18, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 18, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 18, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 16, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2016 | NWAP | NEW APPLICATION ENTERED | — |